滚动资讯
FierceBiotechAACR: FDA vet Pazdur bemoans state of agency, warns of political influence and ‘sense of anxiety’Thermo FisherMerit Financial Group LLC Buys 3,934 Shares of Thermo Fisher Scientific Inc. $TMO - MarketBeatIlluminaIllumina (ILMN) Valuation Check After DRAGEN v4.5 Launch And Major Pediatric Genomics Partnership - simplywall.stThermo FisherThermo Fisher Scientific launches Applied Biosystems™ PowerFlex™ Thermal Cycler - BioSpectrum IndiaAgilentAgilent Technologies Inc (A) Stock Up 3.1% and Still Undervalued -- GF Score: 93/100 - GuruFocusAgilentAgilent Technologies Inc (A) Stock Up 3.1% and Still Undervalued -- GF Score: 93/100 - GuruFocusAgilentAgilent Technologies Inc (A) Stock Up 3.1% and Still Undervalued -- GF Score: 93/100 - GuruFocusAgilentAgilent Technologies Inc. stock outperforms competitors on strong trading day - MarketWatchFierceBiotechUCB pays $650M+ for Neurona, marking 'strategic expansion' into regenerative medicineFierceBiotechMerck unveils PD-1xVEGF bispecific data in NSCLC, remains tight-lipped on phase 3 plansLonza NewsLonza Group AG stock (CH0013841017): Is biopharma contract manufacturing strong enough to unlock new - AD HOC NEWS10x Genomics Blog10X Genomics stock hits 52-week high at 26.07 USD - Investing.com
FierceBiotech 2026年4月17日

Merck unveils PD-1xVEGF bispecific data in NSCLC, remains tight-lipped on phase 3 plans

Merck unveils PD-1xVEGF bispecific data in NSCLC, remains tight-lipped on phase 3 plans

原文
暂时没有全文，请查看原始来源。